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Measuring the Spread of COVID-19 in Kentucky: Do We Have the Right Data? 
by 
Kenneth Troske and Paul Coomes1 
October 29, 2020 
 
Executive Summary 
We examine various measures of COVID-19 infections, hospitalizations and deaths, with an 
emphasis on data for Kentucky. We find that: 
• Data on the number of new reported cases of the disease obtained from convenience samples (as 
opposed to representative random samples) is an inaccurate measure of the spread of the disease 
in the State. Using CDC data and national studies, it appears that there were ten times the 
number of infections in March than reported for Kentucky at the time and by September the State 
is still capturing only one out of two people infected. 
• A better measure of new cases can be obtained from model-based estimates of new daily cases 
that adjusts for the number of people being tested, the demographic characteristics of who is 
being tested, hospitalization rates, death rates, data on mobility, as well as the known biases in 
the reported data.  
• By the end of September, the state had confirmed about 66,000 cases, while model-based 
estimates and CDC data indicate from the that the true number at that point was over 200,000 
cases.  
• There is little indication that Kentucky hospitals were ever in danger of being overwhelmed with 
patients. We estimate that around 1.5-2.0 percent of people who contract COVID-19 end up in 
the hospital while around 0.4 percent of them end up in the ICU, and these numbers have 
remained fairly constant since May. The percent of ICU beds used by COVID-19 patients has 
ranged between 10-15 percent while the rate of hospital bed usage has been in the 3-4 percent 
range. 
• The estimated case fatality rate was around 10 percent at the start of the pandemic, but then fell 
quickly and seemed to level off at around 1.5 percent towards the end of September. In contrast, 
the estimated infection fatality (IFR) rate is fairly constant over the entire period at around 0.7 
 
1 Kenneth Troske is Richard W. and Janis H. Furst Endowed Chair of Economics, University of Kentucky; 
and Paul Coomes is Emeritus Professor of Economics, University of Louisville. This paper was commissioned by 
the Institute for the Study of Free Enterprise at the University of Kentucky. Abby Troske provided research support. 




percent. This is consistent with the State data on new reported cases being an underestimate of 
the number of people who actually contracted COVID-19 
• People aged 80 and older have accounted for around 50% of the monthly deaths since June, 
despite being only 5% of the population of the state. The share of new deaths among people over 
60 has remained fairly constant at around 90%. Over one-half of fatalities have occurred in 
nursing home patients, and the proportion has been stable since March. 
To accurately track the spread of the infection requires random testing of the population, with 
samples that represent people by age, gender, ethnicity, and place. This has been done on a limited scale 
in Jefferson County, as well as in the state of Indiana, but has not been implemented statewide in 
Kentucky. Another promising tool is the sampling of sewage wastewater around communities. This 
method can detect the presence of the virus in a population, even as small as a dormitory or nursing 
facility. While used in Jefferson County, as well as other places around the world, there has been no 
statewide program in Kentucky. 
Evidence on the cost of shutting down schools and businesses, along with the IFR estimates by 
age and the share of deaths in Kentucky by age make clear that people under 65 are paying the biggest 
share of the cost of fighting the disease but are receiving the smallest share of the benefits. Given this, it is 
not surprising that parents are pushing for schools to reopen and people around the world are protesting 
efforts to reclose the economy. It would seem like the best course forward would be to obtain better data, 
and use the reliable data we already have, such as data by on death rates and IFR by age, to better direct 
efforts and resources at fighting the virus so we can protect the elderly and other vulnerable populations 
while keeping schools and businesses open.   
The coronavirus is a serious disease that is imposing enormous costs on the people of Kentucky 
through an increase in the number of people getting sick, being hospitalized, and ultimately dying. 
However, the costs of the polices designed to help slow the spread of the disease, such as closing 
businesses and schools, are also large (See Coomes, 2020 for a discussion of these costs) so it is 
important to ensure that we are adopting the most efficient, effective and well targeted policies to combat 
the disease, which requires having the necessary data to design and assess these policies. Failing to use 
the bests data results in a waste of taxpayer money and unnecessary deaths. Unfortunately, given the 
limitations of the existing data resources, public officials do not have any better understanding of how the 
disease is spreading throughout the State or the deadliness of the disease than they did back in March, 
This means that policy decisions moving forward are going to be as inaccurate as ones made in the past. 
Given the impact of the disease it is hard to understand why the state continues to ignore the 
recommendation of the National Academy of Sciences, Engineering and Medicine, as well as the 
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evidence for random testing programs implemented in Jefferson County and Indiana, and devote at least 
some portion of their testing budget to periodically testing random samples of the population so that we 
can develop better measures of how the disease spreads through communities, a better understanding of 
the fatality of the disease, and better measures to protect the most vulnerable people in Kentucky while 
limiting the economic and social burden of public health policies. Given the enormous costs the disease is 
imposing on Kentuckians, it seems worth making the relatively small investments in collecting better data 






Starting in late February the spread of a new virus—COVID-19—around the world began turning 
lives upside down, including the lives of people in Kentucky. As people learned how potentially deadly 
the virus was they began taking steps to limit their contact with others to try and protect themselves. As 
health officials and policy makers also began sensing the seriousness of the virus they began taking steps 
to limit the spread and impact of the virus by ordering businesses they deemed as nonessential—schools, 
universities, daycare centers, restaurants, bars, theaters, concerts, sporting events, much of retail, and 
government offices—to close, and began urging people who didn’t work in essential businesses to stay at 
home. Many of these efforts came about in reaction to experiences in Italy and New York City where the 
health care systems were overwhelmed by an explosion of people seeking urgent medical care. And while 
there is evidence that these efforts helped slow the spread of the disease (Allcott, et al., 2020, 
Courtemanche, et al., 2020 and Friedson, et al., 2020), these efforts clearly came at enormous immediate 
costs to the economy in the form of unemployment and lost output, and also resulted in costs that will last 
long into the future due to lost schooling resulting from the closing of K-12 schools and universities, as 
well as business bankruptcies (Coomes, 2020, Fuchs-Schündeln, et al., 2020).  
Based on previous pandemics, epidemiologists have developed a sophisticated model—called the 
SIR model—to predict how infectious diseases spread through the population. This model is then used to 
design policies to slow the spread of the virus. Two key parts of this model that indicate the seriousness 
of a virus are the reproduction rate (R)—how many people are infected by a single infected individual, 
and the infection fatality rate (IFR)—how many people who become infected die as a result of the 
disease. However, the COVID-19 virus has features that differ in important ways from other pandemic 
infections. For many previous infectious diseases, such as Ebola, a large percentage of people who 
contract the disease show symptoms and become sick, which results in them being treated by a health care 
provider and tested for the disease. In this situation it is relatively straightforward to track how the disease 
spreads through the population and how many people die from the disease. In contrast, with COVID-19 
we have discovered that many people who become infected either show no symptoms or very mild 
symptoms and the likelihood of being asymptomatic and the likelihood of dying from the disease appears 
to vary by characteristics such as age, gender, race/ethnicity, and co-morbidities. Since people with mild 
or no symptoms are less likely to get tested it is difficult to obtain accurate, unbiased, measures of either 
R or IFR, since primarily the sickest people get tested. Additionally, alternative measures to assess the 
severity of the virus in an area, such as the percent of positive tests and changes in the percent positive 
rate over time, are biased in complex ways that are affected by how many people get tested and by who 
gets tested. These inaccuracies in measures of the severity of the virus then lead to poorly targeted 
policies to combat the spread of the virus. Also, because the bias differs across the different measures 
5 
 
used to track the virus, people tend to focus on the one measure that supports their preferred policy. It also 
leads to uncertainty among citizens about the severity of the disease, which in turn lessens support for any 
proposed course of action. Unfortunately, policy makers nationwide have been slow to adopt alternative, 
but more accurate, ways of measuring the spread of the virus, despite the urgings by leading experts 
(National Academy of Sciences, Engineering and Medicine, 2020).  
We start this paper by providing a non-technical discussion of how the data are collected and how 
the number of tests and who is tested can affect common measures. Next, using data for Kentucky, we 
will present a number of different measures of the spread of the virus in the state to document how the 
virus has spread in Kentucky, but also to demonstrate how changes in different measures can lead to 
different policy conclusions. We will also offer suggestions on alternative ways to collect data on the 
virus as well as ways to combine existing measures that result in more accurate, less biased, measures 
leading to more effective policies.  
 
II. Measuring the Seriousness of COVID-19. 
Based on past pandemics epidemiologists and other health researchers and officials have 
developed two measures to track the seriousness of an infectious disease, the reproduction rate, referred to 
as R or R(t), and the infection fatality rate or IFR. R measures how quickly a disease spreads through a 
given population of people. R is an estimate of how many people are infected by a single person who has 
contracted the disease. Rates above one indicate the disease is expanding in a population and a growing 
number of people are getting sick while rates below one indicate the disease is contracting and fewer 
people are getting sick. Since the reproduction rate changes over time as people undertake efforts to avoid 
getting sick and health officials adopt policies to limit the spread of the virus, the measure typically used 
is the effective R, designated as R(t). (R(0) is the initial reproduction rate when the disease enters a 
population). Given basic math, an R(t) of 2 or 3 is concerning because it indicates that the disease is 
spreading quickly through the population.  
For a disease where almost everyone who contracts the disease shows symptoms and receives 
treatment, then calculating R is fairly straightforward. One can simply observe how the number of people 
who show symptoms changes over time, the number of people hospitalized, and, by contacting people 
who a sick person has come in contact with, can produce a fairly accurate and unbiased estimate of how 
quickly the disease is spreading through a population.2   
However, measuring R(t) is much more difficult in situations like the current pandemic where 
many of the people who contract the disease experience only mild or no symptoms of the disease and 
 
2 If the onset of symptoms occurs sometime after someone has contracted the disease, then adjustments 
need to be made to calculate R at any given point in time.  
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never seek treatment. And even if they contact a physician they are advised to stay home and let the 
disease runs its course unless symptoms become more serious. In this situation, measuring the spread of 
the disease is much more complicated since most people who are tested are those with serious symptoms 
and are likely infected. In this situation, relying on who tests positive for the disease will substantially 
underestimate the number of people with the disease at a point in time, and will bias any estimates of R(t) 
in complex ways. In the simplest case, suppose everyone is equally likely to contract the disease, but a 
fraction who get it show no symptoms. Also assume that the likelihood that one person with the disease 
spreads the disease to someone else is independent of whether the person shows symptoms. Then the 
estimate of the number of people who have the disease at a given time will understate the true number of 
people who have the disease. Data from the surveillance studies conducted by the Centers for Disease 
Control (CDC) in April 2020 (https://www.cdc.gov/coronavirus/2019-ncov/covid-data/serology.html) 
showed that approximately one in ten people who had the coronavirus were diagnosed with the disease, 
meaning the reported number of people who were diagnosed with the disease on a given day substantially 
understated the true number. In this situation in order to measure R(t) you need to build a model that 
incorporates the fact that the number of people who are infected at any point in time is an underestimate 
and then use this model to predict the true R given the bias in the observed data.  
The model becomes more complicated if, as the awareness of the disease grows, people change 
their behavior to limit the chances they become infected, or if governments implement policies to limit 
the spread of the disease (See Allcott et al. 2020 for evidence that this did occur). In addition, if people 
who are not as sick respond by increasing the likelihood they are tested, this should both reduce the 
number of people with the disease who are never tested and lead to a decline in the number of new tests 
that are positive. Another complication arises when people get tested more than once. One reason why 
this occurs is when someone tests positive for the disease, quarantines for a given period, they will then 
be retested, sometimes several times, to make sure they no longer have the disease. Then to measure R(t) 
you have to build a more complicated model to incorporate all of these other factors.3 The problem is that 
without accurate data on who is sick, one has to make assumptions about the influence of these other 
factors, and these assumptions lead to less accurate and biased measures if these assumptions consistently 
understate or overstate the extent of the problem. Evidence showing how the number of people who had 
the disease that were never diagnosed again comes from the CDC surveillance testing which found by 
June that one in four people who had the coronavirus were diagnosed, compared to one in ten in April.  
 
3 All of this assumes that the tests for the disease are perfectly accurate. If they are not, then estimates of 
R(t) need to incorporate the inaccuracies of the test. However, this is true even in situations where 
most people who contract the disease show symptoms.  
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Measuring the true reproduction rate becomes even more complex if we change a few of the 
assumptions made above. There have been a number of studies showing that the elderly are the most 
vulnerable to the coronavirus. A number of factors contributed to this vulnerability including more 
comorbidities which increase the likelihood that someone dies from the virus, and the fact that they are 
more likely to live in congregate living facilities which tended to increase the spread of the disease. A 
recent meta-analysis estimating how the severity of the disease varies by age found that the infection 
fatality rate was close to zero for people under age 44 (0.04%) but rose to 2.4% for those 65-74, 8.9% for 
people 75-84 and 36.8% for people 85+ (Levin et al., 2020). Given the different fatality rates it seems 
likely that people of different ages would take different action to protect themselves in the face of the 
disease, which would lead to different infection rates. This same study found support for this hypothesis, 
reporting an estimated infection rate for people 0-49 of 7.5%, 5.1% for people 50-64, and 4.5% for people 
65+. Similar evidence is found by the CDC in their surveillance studies. This suggests that the number of 
people diagnosed with the disease by the current testing being employed is going to vary not only by the 
number of tests conducted, but also by who is tested. For example, if the elderly were more likely to die 
from COVID-19, it seems likely that they were more likely to be tested during the onset of the disease—
something supported by the limited data on the characteristics of who was being tested in March and 
April. This also means that the bias from using testing data to predict the number of people infected will 
be a function of both the number of tests administered and also who is tested. Testing more people means 
that the estimated infection rate should fall. However, if younger people are more likely to be infected 
then increasing the number of young people tested will lead to an increase in the percent of tests that are 
positive. Now any model designed to estimate R(t) is going to have to incorporate these possible changes 
in both the number of tests and who is being tested using the best guess about how the likelihood of being 
infected varies by age and other demographic characteristics. Incorporating these factors again increases 
the complexity of these models and makes them less accurate and subject to unknown biases. The bottom 
line is that using data from tests of people who choose to be tested leads to an inaccurate and biased 
estimate of how the virus is spreading through society at any point in time.  
Measures of IFR suffer from similar problems as measures of R(t). Since we do not have a good 
count of the number of people infected with COVID-19 it is difficult to measure how many people died 
from COVID-19 relative to the number infected with COVID-19. Again, since not everyone shows 
symptoms and is tested, it is not clear that every death from COVID-19 is being captured. Since many 
people who die from COVID-19 also have other comorbidities some COVID-19 deaths may be attributed 
to other factors. Of course, the converse can also be true. There is some evidence that the undercount of 
deaths from COVID-19 is smaller than the undercount of those who have the disease (Heuveline and 
Tzen, 2020). In addition, even though the death rate may be a more accurate estimate of how the disease 
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is spreading, given the delay between the onset of the disease and death, it is a less timely measure. 
However, if one is primarily interested in tracking the spread of the disease, measures of death rates do 
appear to be a better measure of the spread.  
Because of the complexity in measuring R(t) and IFR, public health officials have turned to other 
measures to judge how the disease is spreading and to inform policy efforts to limit the spread of the 
disease. The problem is that most of the measures being used suffer from the same problems that plague 
efforts to measure R(t). The National Academes of Science, Engineering and Medicine (NAS), a group of 
the leading researchers in the U.S., issued a report in June 2020 discussing the strengths and weaknesses 
of many of the measures being used to track the spread of COVID-19 (see National Academy of Sciences, 
Engineering and Medicine, 2020). This report concluded that the primary measure reported and used by 
officials in Kentucky, the fraction of tests that are positive, has the advantage of being timely but likely 
overstates the proportion of people with the disease at a point in time. They also point out that this 
measure will be affected both by the number of people being tested as well as the age and race/ethnicity 
of who is being tested. The NAS report expressed similar concerns about measures such as the 
hospitalization rate (whether measured per case, per infection, or per population) or the number of 
confirmed cases. NAS also expressed concerns about the lag and accuracy of measures based on reported 
deaths.  
It is worth noting that measures such as the number of confirmed cases and hospitalization rates 
are used to track the virus because of concerns that the spread of the virus could overwhelm the healthcare 
system in a region. And while this was certainly a legitimate concern initially, only in a few isolated cases 
such as Wuhan, China, Italy and New York City did this ever become an issue. Officials seem to have 
shifted to using these same measures to assess the appropriate policy responses to the virus, for which 
these measures are not as well suited.  
One measure that the NAS report singled out for having the least bias and being the most accurate 
were results obtained from prevalence surveys or tests of random samples of the population. Why is this 
the case? First, if random samples are truly random, then they will incorporate differences in infection 
rates by demographic characteristics and will effectively control for these differences thereby producing 
an unbiased estimate of the number of people infected at a point in time. The accuracy of these tests is 
easily adjusted by altering the number of people being tested. In addition, it is much simpler to calculate 
R(t) using the results from tests of random samples of people at different points in time. With random 
samples the estimate of the infection rate will not be affected by the number of people tested (although the 
accuracy will be) nor by who is being tested since you are always testing the “same people.” Tracking 
infected people after they have been tested will show the percentage of people who die from the virus, 
providing an accurate estimate of IFR at a point in time. The one limitation of random testing is 
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timeliness. It will take time to process all the tests from a random sample of the population, so it may take 
a week or two to have an estimate of R(t) from a specific date. This makes it less desirable to measure the 
likelihood that the health systems will be overwhelmed, but again, given that this has not happened except 
in a few extreme situations, this seems like a less important limitation.  
The advantage of repeated random testing is it provides the most accurate, least biased, measure 
of R(t) and IFR, and therefore, the most accurate measure of the severity of the disease at a point in time 
and how the severity changes over time. It also allows one to compute an accurate measure of how the 
infection rate and death rate varies by important demographic characteristics such as age and 
race/ethnicity. Given these advantages one obvious question is why there are so few examples of 
governments undertaking regular random sample testing of the population? One argument is cost, because 
it is expensive to draw random samples of the population, setting up locations where they can be tested, 
convincing individuals to come in and get tested and then following them over time. Of course, most state 
and local governments have already set up testing locations and are spending a substantial sum of money 
on testing, so it seems likely that they could afford to devote some portion of their testing budget to 
efforts that would provide more accurate, less biased measures of how the disease is spreading through 
the population. In addition, accurate data allows policy makers to design less costly policies better 
targeted towards protecting the most vulnerable people in the population as well as to accurately assess 
the effectiveness of existing policies. A study by Acemoglu, et al. (2020) estimates that polices better 
targeted to protect the most vulnerable people could achieve the same outcome we achieved by shutting 
down large parts of the economy, at almost half the cost. Accurate measures of the spread of the disease 
could also limit criticism of policies that are based on inaccurate and biased estimates. We discuss these 
issues further below.  
The report from the NAS suggests that officials should use a variety of measures to assess the 
spread and seriousness of the disease instead of relying on any single measure. The report also leads to 
the conclusion that random sampling over time should be an important part of any testing regime. In 
section IV of this report we will present graphs on many of the measures discussed that are specific to 
Kentucky. These graphs will provide a view of how the virus has spread in Kentucky as well as illustrate 
how these measures can be affected by minor changes in assumptions underlying the graphs. Before 
doing so, in the next section we discuss the data we use to construct the various measures 
 
III. Data used to measure the spread of the virus in Kentucky 
Most of the data used in this paper come from the COVID Tracking Project 
(https://covidtracking.com/). The COVID Tracking Project is a voluntary organization that arose out of an 
article published in The Atlantic about the lack of data being systematically compiled to track how 
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COVID-19 was spreading in the U.S. and in separate states. These data are collected by systematically 
scraping data from web pages for all 50 states and five U.S. territories. For Kentucky these data are 
obtained from the state web page that reports the daily updates for COVID-19 
(https://govstatus.egov.com/kycovid19).  
We have chosen to use the COVID Tracking Project data for several reasons. First, they are 
updated daily and all of the new as well as historic data are available in an electronic format. Also, data 
are available back to early March. In contrast, the data on the Kentucky web site is only provided daily as 
a pdf document and only recently have older daily reports been made available, and these are only 
available starting June 1. Also, while the state tries to eliminate duplicate tests from their data, it is not 
clear how this is done. In contrast, the COVID Tracking Project documents how they process the data. 
Finally, the COVID Tracking Project are the data used in a number of academic studies and efforts to 
produce model-based estimates of the spread of the virus, making it easier to compare our measures with 
measures for other states and the U.S as a whole. We will supplement the COVID Tracking Project data 
with data from other sources, including some additional data, such as the number of confirmed cases by 
age and the number of confirmed deaths by age, available from the Kentucky COVID-19 web site 
(https://govstatus.egov.com/kycovid19).  
We also use data from the Institute for Health Metrics Evaluation (IHME) as well as surveillance 
data on the extent of past infection from the CDC. IHME is one of several groups using data collected by 
The COVID Tracking Project to model the spread and deadliness of the disease taking into account that 
all of the data come from individuals who chose to be tested—that is, taking into account that tests are not 
based on random samples of the population so results are potentially biased estimates of the spread and 
seriousness of the disease. We will focus on IMHE data for Kentucky. The CDC surveillance data 
primarily come from measuring seroprevalence (antibodies) in blood samples from various locations 
around the country that were collected for other purposes (blood tests ordered by doctors, people donating 
blood, etc.). These data are still a convenience sample, so they are still potentially biased relative to data 
from true random samples, but they are a much larger samples and likely contain less bias than samples 
taken from people who chose to be tested. In addition, the CDC adjusts these data for age and other 
characteristics of who is being tested to make them more representative of the population (something the 
state of Kentucky is not doing when presenting the number of confirmed cases).  
Finally, we also present data from the rt.live web site. Rt.live presents model-based daily 
estimates of R(t), again taking into account the problems with the reported data. Like IHME, rt.live uses 
data from the COVID Tracking Project in their models. The IHME data, combined with surveillance data 
from the CDC and data from rt.live, provide evidence on the inaccuracy and bias of the data being used 
by national, state and local governments. They also help illustrate the point that all the data being used, 
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included data on “confirmed” cases are estimates of who is infected. As the NAS report indicates, all 
these estimates have known issues with accuracy and bias. Absent data from random samples, one is often 
forced to trade-off biased estimates that are timely, with less biased, and therefore more accurate, 
estimates that have a longer lag. Part of the point we are making here is that it is important to understand 
these biases and inaccuracies when formulating and evaluating policies to minimize the impact of the 
virus. And it is important to use a variety of different measures—including those obtained from random 
samples—when trying to formulate the most effective policies.   
 
 
IV. Measuring the Spread and Impact of the Coronavirus in Kentucky 
a. Measuring the spread of COVID-19 
We begin our analysis of the spread of COVID-19 in Kentucky with Figure 1, which presents the 
daily number of new reported cases of COVID-19 based on confirmed positive tests. One of the issues 
with reported cases is that they vary substantially based on the day of the week simply because many labs 
and testing sites are not open on weekends. Moreover, often several days of test results are ‘dumped’ at 
once into the state database. To control for this variation, we graph the seven-day moving average of the 
number of reported cases. According to the State, the first recorded COVID-19 case in Kentucky was 
March 6. 2020, so the first date we start reporting is March 12. In many of the figures we also add a line 
on the date the Governor ordered schools and non-essential businesses to close—March 16—the date 
restaurants and most retail were allowed to re-open with some restrictions, May 22—and the date the 
Governor issued a mandatory mask order, July 10. Finally, all of our main graphs use data through 





As seen in Figure 1, the reported number of cases rose slowly for a few days, but then began to 
rise quickly reaching an initial peak around May 10. Reported cases then began an unsteady decline 
before leveling off around June 18. Cases then began to rise quickly again after the 4th of July before 
again reaching a plateau around the end of August and continuing into September. For September the 
average number of new cases a day is approximately 524 but there is a substantial amount of daily 
variation around this number.  
Examining these data makes clear how much variation there is in the day-to-day number of 
reported cases, even after the data have been smoothed. Clearly, the more testing that is performed the 
more positive cases will be found. Figure 2 provides some evidence for this, though the relationship is not 
perfect because the number of positive cases is also a function of who is being tested. In this figure the 
blue line shows the number of new viral tests conducted per day while the red line shows the number of 
new cases reported from viral tests per day. This figure shows that the number of new cases detected 
generally increases with the number of tests given, though in July the number of cases rose at a much 
faster rate than tests, suggesting a higher underlying positivity rate. For much of the month of August the 
number of new tests hovered around 9,000, new detected cases hovered around 500. New tests increased 
dramatically starting in middle September, rising to around 20,000 and jumps again to around 30,000 in 
the last week and a half of the month. Over this period the seven-day average of new positive tests jumps 
from around 450 to around 580. It is not clear why the number of tests jump in the middle of September, 
although it may be related to the fact that colleges and universities in the state were testing all students 









KY closes schools, 
restaurants, etc.
Restaurants, most retail, 
allowed to reopen, with 
restrictions
KY issues mandetory mask order
Figure 1 - Daily New Diagnosed Cases in Kentucky, 7-day moving average
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Moreover, the number of positive cases is misleading when the number of tests changes so much 
between the early and later periods. In particular, the testing rate through early May was extraordinarily 
low, so that comparing the number of positives in the period before May with the number of positives 
after that is not really valid, also implying that the so-measured long-term trend in positivity is 
misleading. The large shifts in testing induces confusion into the interpretation one might give to the 
observed pattern of numbers of positive tests. 
Another the reason for the observed variation in the data is that testing is mainly voluntary, so 
who chooses to show up on a given day for a test is still random and why someone might get tested has 
likely changed over time. Initially people who got tested were told to by a doctor or had a job, such as 
working in a hospital or a nursing home, that required them to be tested. Recently, however, tests have 
become more readily available so now people get tested prior to traveling and often after they return 
home so they can avoid quarantining or if they are going to visit an older relative, or for a myriad of other 
idiosyncratic reasons. We are now testing athletes on a regular basis as well as many other K-12 and 
college students. All of this means that the number of people who show up to be tested on any given day, 
as well as the characteristics of who shows up varies substantially over time.  
One example of how the number of reported infections might change over time as a result of who 
is being tested comes from testing students as they started the fall semester. As was mentioned above, 
recent estimates of the infection rate by age shows that people under age 49 are 1.5 times more likely to 
be infected then people 65 and older.4 If we devote a larger share of tests to young people going to 
college, then we could see an increase in the number of positive tests even if there is no change in the 
 



















Figure 2 - Daily New Tests and New Diagnosed Cases in Kentucky, 7-day moving average
Source: The Covid Tracking Project, https://covidtracking.com/  
14 
 
underlying infection rate in the population. This possibly accounts for some of the increase in new 
positive cases seen towards the end of September. 
 
 
Understanding the variation in both the number of new cases and the number of new tests is 
important because the number of new cases divided by the number of new tests—what is often referred to 
as the percent positive, or positivity rate—is a common measure used to determine how quickly the virus 
is spreading in an area. This is what is presented in Figure 3.5 As Figure 3 shows, this number was quite 
high back in March, but fell substantially to around 6% in August and fell further in September to around 
4%. Again, however, there is a substantial amount of variation in this number making it difficult to draw 
strong conclusions from daily movements. As the NAS report and the example above makes clear, the 
percent positive rate will be affected both by the number of tests as well as the demographic 
characteristics of who gets tested, meaning that it is important to combine movements in this number with 
other measures before drawing strong conclusions about how the virus is spreading in an area. 
Figure 4 presents estimates of the actual number of new cases of COVID-19 a day based on the 
IHME model—the solid blue line—along with an upper and lower bound for the estimates—the dashed 
black lines. This model uses data on reported cases, confirmed deaths, hospitalizations, individual 
mobility in an area (based on data obtained from cell-phones), protective measures in an area, such as 
 
5 Kentucky calculates the percent positive rate by dividing the number of new positive cases and number of 
new tests based on virology tests. Here we are using all tests since this is comparable to the estimates 
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Figure 3 - Reported Daily New Diagnosed Cases as a Percent of New Daily Tests in Kentucky, 7-day moving average 
Source: The Covid Tracking Project, https://covidtracking.com/  
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mandates for wearing masks along with information on who is being tested in an area, to develop their 
best estimate of the true number of COVID-19 cases in a day. It is important to recognize that one of the 
advantages of these estimates is the people developing the IHME estimates recognize that they are 
estimates and produce an upper and lower bound for the estimates, providing a measure of the uncertainty 
associated with the estimates. In contrast, when reporting the number of new reported cases, which is also 
an estimate of the true number of new cases, state officials do not provide any bounds indicating the level 
of uncertainty associated with this estimate. Instead they are treated as if they are the true count. 
 
The blue line in Figure 4 shows a much higher rate of infection throughout the period than is seen 
in Figure 1, particularly early in the pandemic. Figure 1 shows an initial peak in daily reported infections 
in early May at around 200 new cases a day. In contrast, Figure 4 indicates that the peak in infections 
likely occurred in late March/early April at around 1,250 infections a day before declining steadily 
through early June. Both figures indicate that cases began rising again in early July, but Figure 1 suggests 
that the new peak reached in early September of 634 cases a day was over three times larger than the peak 
in early May, while Figure 4 shows the second peak was comparable to the estimated number infections 
we saw in April.  
Comparing Figures 1 and 4 makes clear that it is inappropriate to compare the number of new 
confirmed cases being reported currently with the number reported earlier in the pandemic to draw 
conclusions about whether the daily rate of new infections is “high” or “low”. Estimates by the CDC 
based on surveillance data showed that in April actual cases were ten times higher than reported cases. 
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Figure 4 - Estimated Actual New Cases in Kentucky, 7-day moving average




were around 1,600 new COVID-19 cases a day in Kentucky, which is slightly above the upper estimate of 
the IHME model. By June the CDC data suggests actual cases were four times higher than reported cases. 
Again, applying this to the data on reported cases for Kentucky suggests that actual new cases were 
around 680, which is close to the IHME estimates. Finally, comparing the recent IHME estimates for 
Kentucky with the reported data suggest that actual cases are twice as large as reported cases, meaning 
that the true number current cases is around 800 confirmed cases a day. Using data from CDC along with 
the estimates from IHME again suggests that in the current period the actual number of new cases is 
comparable to, or below, the number of cases we saw back in April. These data also make clear that 
statements in the media claiming that COVID-19 cases are at record levels are likely to be wrong given 
how many undiscovered cases there were in April and May.  
  
Next, Figure 5 plots the total number of COVID-19 cases in Kentucky as of a given date using the 
number of confirmed cases reported by the state—the blue line—and the estimated number of cases 
reported by IHME—the red line. Based on the State data as of September 30, there have been 66,484 
cases of coronavirus in Kentucky, while based on IHME data there have been 201,163 cases by this date.6 
These are very different numbers and paint a much different picture of the spread of the disease in 
Kentucky. As of August 2, based on their seroprevalence estimates for Kentucky, the CDC estimated that 
2.1 percent of the population in Kentucky had contracted the disease, with a lower bound estimate of 1.2 
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Figure 5 – Total Number of Confirmed Cases and Estimated Cases in Kentucky, 7-Day Moving Average 
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percent and an upper bound estimate of 3.3 percent. The IHME estimates indicate that approximately 2.8 
percent of the population of Kentucky had been infected by August 2, which is within the bounds of the 
CDC estimate. In contrast, based on the reported number of cases from the state 0.7 percent of the 
population had been infected, which is well below even the lower bound of the CDC estimates. The data 
on new cases reported by officials in Kentucky appears to be a significant underestimate of the true 
number of cases.  
 
Figure 6 plots the estimated effective reproduction rate or R(t) by day using the estimates 
available from the rt.live web site. These data show that the virus was spreading very quickly initially, 
with initial estimates of R(t) above 2 back in March. However, the reproduction rate dropped quickly and 
by the beginning of May the estimated rate was around 1.0. It began rising again at the beginning of June, 
reached a peak of around 1.19 toward the end of June before falling again through the end of August. 
Recently there has been an increase to around 1.2, but given the uncertainty surrounding the latest 
estimates it is difficult to tell the exact size of any increase. However, the reproduction rate remains well 
below the levels seen in the beginning of April and appears comparable to the rates seen in the end of 
June. This pattern is much more consistent with what we have seen with IHME data, but very different 
















Finally, Figure 7 shows the share of new cases reported by age for each month starting in June. 
These data come directly from the information on the state web page 
(https://govstatus.egov.com/kycovid19) since this information is not collected by the COVID Tracking 
Project. We start in June because the state does not report the share of cases by age for earlier months. In 
order to put the numbers in the graph in context it is important to know that people 0-19 make up 24% of 
the total population in the state, people 20-39 make up 26% of the population, people 40-59 are 25%, 
people 60-79 are 20%, and people 80 and older make up 5% of the population of Kentucky. The graph 
shows that since June the group most likely to get infected is those 20-39 years old. Approximately 35% 
of the new reported cases every month occur among people this age, despite accounting for only 26% of 
the population. The next largest share of cases occurs among people 40-59 with around 27% of cases 
which is comparable to their share of the population, while people under 19 account for around 19% of 
the cases while accounting for 24% of the total population. People aged 60-75 account for around 16% of 
the cases which is less than their share of the population, while around 4% of people 80 and older are 
infected which is comparable to their share of the population. In addition, it is also true that the share of 
new cases among people over 60 has remained fairly constant at around 20%, despite efforts to minimize 
the likelihood that these folks contract the disease.  
An obvious question is why are those in the 20-39 age cohort so prone to getting the disease? 
Unfortunately, without test results from a random sample of the population along with information about 
their habits, it is difficult to answer this question. One possibility is that this group is more likely to work 
















Figure 7 - Share of New Cases in a Month by Age in Kentucky




we shall see, it is the case that people aged 20-39 years are the least likely to die from the virus, so it may 
be that they take this into account and take fewer measures to protect themselves. Unfortunately, given 
the lack of appropriate data, all we can do is speculate. It is a very important issue, however, as younger 
people dominate the workforce, and better measures may have allowed us early on to target policies to the 
elderly and vulnerable, letting others continue working. 
One thing we have seen from the figures presented is that data from IHME, the CDC and rt.live 
paint a fairly consistent picture of the spread of the virus in Kentucky—initially it spread fairly quickly 
and a large number of people were infected. Since then, while there have been some increases and 
decreases, the spread has slowed, and the reproduction rate has hovered around or slightly above one. In 
contrast, the rate of infections reported in the media gives the impression that the virus has been spreading 
more quickly lately, primarily because the testing done by the state missed most of the people who 
became infected early in the pandemic. Next, we turn to examining some measure of the outcome of the 
virus—hospitalizations, the use of the ICU, and death rates.   
b. The Hospitalization rate and the rate of people being admitted to the ICU 
Figure 8 presents the reported and estimated rate of COVID-19 cases that end up in the hospital 
and in the ICU. The CDC provides an estimated timeline for how the disease affects an individual  
(https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html). These estimates indicate that 
the median time between becoming infected and being hospitalized is between seven and fifteen days.  
Using this information we construct the estimated hospitalization and ICU rates (the red and green lines) 












Restaurants, most retail, 
allowed to reopen, with 
restrictions
KY issues mandetory mask order
Figure 8 - Reported and Estimated Rate of Hospitilizations and ICU in Kentucky, 7-day moving average
Source: The Institute of Health Metrics and Evaluation, 




divided by the number of new reported cases 11 days earlier. For the estimated hospitalization and ICU 
rate (the blue and yellow lines) we divided the reported numbers of new people entering the hospital and 
ICU on a given day by the IHME estimate of the true number of new infections eleven days earlier. 
Similar to Figure 1 the number of new cases on a given day is based on a seven-day moving average of 
the numbers actually reported by the state and by IHME.  
This figure shows a similar pattern to what we have seen in the other graphs. Using the data 
reported in the media leads to a pattern that displays a large amount of variation. In contrast the estimates 
suggest much lower rates and smaller swings in the rate of hospitalization and the rate of people entering 
the ICU. However, all lines suggest that the rate of hospitalization and ICU usage was higher early in the 
pandemic but has declined in the more recent period. Using the estimated data shows that around 1.5-
2.0% of people who contract COVID-19 end up in the hospital while around 0.4 percent of them end up 
in the ICU, and these numbers have remained fairly constant in the recent period.  
Of course, public health officials and others are rightfully concerned about whether the spread of 
the infection will overwhelm the health care system. To assess how the infection is impacting the 
healthcare system in the state, Figure 9 plots the percent of total hospital beds and total ICU beds in the 
state that are occupied on a given day by patients with COVID-19 while the data on number of hospital 
beds and number of beds in the ICU comes from data reported by IHME.7 The data on number of patients 
currently hospitalized and currently in the ICU on a given day come from the state reported data. We 
 
7 IHM|E reports that there are 16,156 hospital beds and 1,215 ICU beds available in Kentucky on average 
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Figure 9 - Percentage of Hospital Beds and ICU Beds used by COVID-19 Patients, 7-Day Moving Average, Kentucky




again use a seven-day moving average for both numbers to smooth out reporting fluctuations. This figure 
shows that, initially close to 20% of ICU beds in the state were occupied by COVID-19 patients while 
around 2.5% of total hospital beds were occupied by people with the coronavirus. More recently the 
percent of ICU beds used by COVID-19 patients has ranged between 10-15% while the rate of hospital 
bed usage is in the 3-4% range. While it is clearly important to keep track of this number, it currently does 
not appear that the spread of the virus is overwhelming hospital resources in the state.  
c. Fatality Rates 
Officials often argue that fatality rates are not a good way to track the spread of the virus because 
there is a delay between the time a person contracts the disease and when they die from it, so it is a 
lagging indicator. This is certainly true, but as has been argued by others (i.e., Heuveline and Tzen, 2020 
and Meyerowitz-Katz and Merone, 2020), the reported number of deaths relative to the true number of 
deaths appears to have less bias than the reported number of cases relative to the true number of cases. In 
addition, as we report below, the reported number of deaths are similar to the estimated number of deaths 
from other sources, which indicates that they are potentially another important measure to use in assessing 
both the spread and severity of the virus.  
We start with Figure 10 which plots data on the reported number of daily deaths resulting from 
COVID-19. Again, to smooth over issues with the timing of when deaths are reported, we plot a seven-
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Figure 10 - Reported Covid-Related Deaths per Day in Kentucky, 7-day moving average




people were dying from COVID-19 a day. By the end of June the number of deaths had fallen to around 5 
deaths a day, but by the end of the period the number of deaths is comparable to what we saw initially—
around seven to eight deaths a day. This pattern corresponds to the pattern of estimated new cases seen in 
Figure 4.  
Another measure of deaths that is used to track the spread and seriousness of COVID-19 is the 
number of excess weekly deaths in a region8. To calculate the number of excess deaths in a region the 
CDC starts with the actual number of weekly deaths over the previous three years. They use these data to 
estimate the average expected number of deaths in a week in a region, as well as an upper threshold of the 
expected number of deaths in a week in a region. Excess deaths are then calculated in two ways. First, as 
the difference between the actual number of deaths and the upper threshold of the expected number of 
deaths, when the actual number of deaths exceeds the upper threshold of expected number of deaths. If 
the difference is less than or equal to zero (if the actual number of deaths is less than or equal to the 
threshold value) then excess deaths are zero. This is a lower bound estimate of the number of excess 
deaths in a week in a region. The second measure is the difference between the actual number of deaths 
and the average expected number of deaths when the actual number of deaths exceeds the average 
expected number of deaths. If the difference is less than or equal to zero then the number of excess deaths 
is zero. This is an upper bound estimate of the number of excess deaths in a region in a week.  
The NAS report views excess deaths as a better measure of deaths due to COVID-19 than the 
reported number because of issues with trying to assign the cause of death. More recently concern has 
been expressed that excess deaths may be an undercount of the true number of COVID-19 related deaths 
because socially isolating may lead to fewer people dying from other infectious diseases such as 
pneumonia or influenzas. However, it is an alternative measure that is worth considering.  
Figure 11 shows the total number of deaths per day in Kentucky—the blue bars—along with a 
black dashed line showing the upper threshold of the expected number of deaths in Kentucky in a week 
during this period, and the solid purple line showing the average expected number of deaths in Kentucky 
in a week during this period. The first measure of excess deaths—the lower bound estimate—is measured 
as the difference between the top of the blue bar and the dashed line in weeks where the top of the blue 
bas lies above the blue bar. For example, for the week of 5/9/2020 the top of the blue bar, or the actual 
number of deaths, is at 1,011 while the black dashed line is at 979, so the number of excess deaths in 
Kentucky in this week is 32 (1011-979). In the week of 6/6/2020 the lower bound estimate of the number 
of excess deaths in Kentucky would be 0 because the top of the blue bar lies below the black dashed line.  
 




The second measure of excess deaths—the upper bound measure—is the difference between the 
top of the blue bar and the solid purple line in weeks where the top of the blue bar is above the solid 
purple line. For example, again looking at the week of 5/9/2020 the purple line is at 909 so the upper 
bound estimate is 102 (1011-909). Over this period, the only weeks in which the number of excess deaths 
is 0 using the second measure are the weeks of 3/21/202 and 3/28/2020.   
Figure 11 shows that for several weeks early in the pandemic the number of excess deaths is zero 
based on the upper threshold estimate of the number of deaths, even though there were people were dying 
from COVID-19. As we mentioned above, the likely reason for this is that with non-essential businesses 
closed and many people staying at home there were less deaths due to other things such as automobile 
accidents, violent crime or other infectious diseases such as pneumonia or influenza. Starting in May, 
however, the number of actual deaths consistently exceeds the upper threshold of the expected number of 
deaths as well as the average expected number of deaths.  
Summing the measure of excess deaths based on the upper threshold of the expected number of 
deaths between the beginning of April and the end of September there were 891 excess deaths in 
Kentucky. This is below the reported number of COVID-19 deaths of 1,065, consistent with this estimate 
of excess deaths being of lower bound of the number of COVID-19 related deaths. However, summing 
the number of excess deaths in Kentucky over this period based on the average expected number of 
deaths in the State indicates there were 2,470 excess deaths over the period, consistent with this being an 
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upper bound on the estimate of the number of COVID-19 related deaths. The fact that the reported 
number of deaths lies between the two bounds suggested that the reported number of COVID-19 related 
deaths is a reasonable estimate of the actual number of COVID-19 related deaths and therefore that the 
reported number of COVID-19 related deaths is a more accurate measure of the spread of the disease in 
the state than the reported number of new cases.  
Figure 12 plots an estimate of the case fatality rate (CFR) and the infection fatality rate (IFR). 
The case fatality rate is the number of people who die from COVID-19 divided by the number of people 
who are reported to have COVID-19. The infection fatality rate is calculated as the number of people who 
have died from the disease divided by the estimated number of people who contracted from the disease. 
The CDC timeline discussing how the virus affects individuals indicates that the time to death for people 
who die of the disease is between 15 to 30 days. Therefore, to calculate the case fatality rate (the red line) 
we divide the number of COVID-19 reported deaths on a given day by the number of new reported cases 
18 days earlier. To calculate the infection fatality rate (the blue line) we divide the number of reported 
COVID-19 deaths on a day by the estimated number of true infection 18 days earlier. The estimated case 
fatality rate is around 10% at the start of the pandemic, but then falls quickly and seems to level off at 
around 1.55 towards then end of the period. This is what one would expect since early in the period we 
were only testing the sickest people who would be more likely to die from the virus. In contrast, the 
estimated infection fatality rate is fairly constant over the entire period at around 0.7%. This estimate of 
the IFR is nearly identical to the estimated population IFR reported in Meyerowitz-Katz and Merone 
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Figure 12 - Estimated Case and Infection Fatality Rate in Kentucky, 7-day moving average
Source: The Covid Tracking Project, https://covidtracking.com/ 




suggesting the IFR in Kentucky is similar to the IFR in the country. The graph and these other studies 
make clear that the actual fatality rate from COVID-19 is less than the estimated rate based on the 
reported rates of new cases released by the State. 
Finally, Figure 13 plots the number of new monthly reported COVID-19 deaths by age between 
June and September. These data again come directly from the state of Kentucky web page. As this chart 
makes clear, almost no one under the age of 40 has died from the disease in Kentucky (the share is 
essentially zero). In addition, the monthly share of COVID-19 deaths accounted for by people 40-59 has 
dropped from 12% in June to 8% in September, likely reflecting the increase in testing that occurred over 
this period. The share of deaths among people 60-69 has varied between 40 and 46% since July, which is 
quite high given that they only account for 20% of the population in the state (see Figure 7b). Finally, 
people 80 and older have accounted for around 50% of the monthly deaths since the June, despite making 
up only 5% of the population of the state.  These numbers are consistent with the IFR rates by age 
reported by Levin et al. That we discussed previously. It is also note-worthy that since June the share of 
new deaths among people over 60 has remained at around 90%. Recall in Figure 7 we saw that the share 








Regardless of which numbers one uses, there is no question that the coronavirus has had a 
significant impact on the health of Kentuckians. As of September 30, based the reported number of deaths 
by cause, almost 1,200 Kentuckians have died of COVID-19 over the past seven months. (For context, 
Kentucky has about 3,800 deaths per month, from all causes.) Data from IHME and the CDC indicate that 
over 200,000, or over 4% of people in the state, likely have contracted COVID-19 since March. Given 
these numbers it is clear that we should be trying to adopt effective strategies to minimize the impact of 
COVID-19 on the citizens of Kentucky.  
The problem is that when you compare the numbers being used by the state to assess the spread 
of the virus with the numbers being produced by other organizations such as the CDD, IHME and rt.live, 
the data being used by the state is an inaccurate and biased estimate of the true number of new cases and 
total number of cases. And while the accuracy seems to have improved over time, the state still appears to 
only measure one out of two cases of people who have COVID-19, and the accuracy varies substantially 
by day. This in turn leads to the mistaken conclusion that the virus is affecting more people recently than 
in the past. In contrast, the estimated data produced by IHME and rt.live as well as the data from the CDC 
suggests that the number of new daily infections occurring in at the end of September is comparable to the 
number of new infections that occurred in April, and that the reproduction rate has hovered near one since 
April.   
The reason for the continued inaccuracy is that the state data on reported infections are collected 
using a convenience sample—people who voluntarily show up to be tested. Given the variation we have 
seen in true infection rates by age (as well as the reported variation in the infection rate by race and 
ethnicity), the number of reported cases is going to be a function of not only the number of tests, but also 
who is tested on any given day.  
All of this means that you need to use data on reported new infections along with data on 
hospitalization and deaths to produce model-based estimate of the actual rate of new infections to obtain a 
more accurate estimate of how the virus is spreading at a point in time. This is why IHME and rt.live use 
this information, along with data on who is being tested, in order to develop measures of the spread of the 
disease that more closely match measures from the CDC based on serology surveillance.  However, an 
even better strategy would be for the state to conduct periodic testing of random samples of the 
population, as has been done in Jefferson County, the state of Indiana, and elsewhere.9 This would allow 
the state to develop an unbiased estimate of the number of people infected at a point in time as well as an 
 
9 See https://louisville.edu/envirome/thecoimmunityproject/communitystudy  
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unbiased measure of the reproduction rate over a given period. In addition, the state could collect data on 
age, race, ethnicity, location, living arrangements, and whether someone is working, which would then 
allow them to construct unbiased estimates of how the infection rate varies by all of these factors. This 
would allow the state to develop even more accurate ways of adjusting results from the daily tests so that 
they would have an accurate picture of how the spread of the virus in the state. Given the 
recommendations in the recent report by the experts at the National Academies of Science, Engineering 
and Medicine it is hard to understand why Kentucky (and most other states) have not adopted this policy.  
One obvious question is why should the state want to spend resources to conduct random testing 
of the population? What changes in policy might more accurate data produce?  To start, using better data 
would allow us to develop more accurate measures of the number of people infected with the disease in a 
point in time and also allow us to assess what changes in the number of new infections are likely due to 
chance or reflect a true increase or decrease in the spread of the disease. This would allow the people of 
Kentucky to obtain a more accurate picture of the seriousness of the disease and better to assess the 
appropriate actions to take to protect themselves and others.   
In addition, more accurate data allow a more accurate evaluation of the effectiveness of policies 
being adopted to slow the spread of the virus. For example, at the start of the pandemic there were a 
number of studies estimating the costs and benefits of the efforts to shut down businesses, government 
offices and schools using state data on confirmed cases to estimate the potential spread of the virus (e.g., 
Courtemanche, Garuccio, Le, Pinkston and Yelowitz (2020), who use data from Kentucky, and Friedson, 
McNichols, Sabia and Dave (2020), who use data from California). These studies tend to find that the 
benefits of these measures exceeded the costs. Since the data they used to obtain their estimates 
significantly understated the spread of the disease early in the pandemic, and this bias varied by location 
because of differences across regions in the characteristics of who was being tested, their results are more 
uncertain that they would be if they were based on more accurate data. This does not mean that the 
measures employed by the state were not ultimately effective, but it does mean that the estimated benefits 
were likely distorted by the biased data. We can see this in the recent study by Allcott et al. (2020) who 
take into account differences in population density and demographic characteristics in a region and model 
the estimated number of new cases of COVID-19 and find that policies shutting down the economy were 
less effective than earlier estimates that did not take these factors into account. More accurate data would 
have allowed these earlier researchers to produce better estimates of which policies worked and which did 
not, which in turn would help produce even more effective new policies to combat COVID-19.  
One policy we continue to struggle with in Kentucky is reopening K-12 schools as well as 
colleges and universities. The available evidence on the cost to students of keeping schools closed is that 
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this is one of the costliest policies we could adopt, and it will have large negative long-run impacts on 
today’s youths, both in terms of lost education and socialization. One recent study estimates that impact 
of a six-month closure of schools is approximately a 1 percent loss in lifetime income (Fuchs-Schündeln, 
Krueger, Ludwig and Popova, 2020). The present value of lifetime income for the typical Kentuckian 
with an associate degree is around $1 million, so this translates into a loss of $10,000 per student. 
Previous studies put the estimated loss as high as $15,000 per student.10 Multiplying these number by the 
approximately 846,000 kids between 5 and 19 years old in Kentucky leads to an estimated cost of 
shutting down schools for six months of between $8 and $12 billion. And this number does not capture 
the lost income that occurs because parents of these children either cannot work or have to work less 
because their children are at home and they need someone to care for them as well as help navigating the 
new online learning environment. Nor does it capture the likely increase in child abuse that occurs when 
schools close. Finally, as is discussed in the Fuchs-Schündeln et al. paper, these costs disproportionately 
affect low-income students of color because these parents are not as able to help their children with their 
schooling and because low income households have less available technology. Clearly, a policy like 
closing schools needs to produce enormous benefits if it is going to be cost effective.  
However, based on the available data it is hard to see how closing schools can produce benefits 
that exceed the costs. To start with, previous studies, such as Courtemanch et al. (2020), found that 
closing school had no impact on slowing the spread of the virus. This is also consistent with Figure 4, 
which shows that the estimated true number of new cases in September is similar to what it was at the end 
of March immediately after schools were closed. In addition, the estimated infection fatality rate is the 
same now as it was back in March, and it remains the case that over 90 percent of new deaths are 
occurring among the people 60 and over even with schools being closed. Finally, 59 percent of all 
COVID-19 deaths in the state have occurred in long-term care facilities and this has not changed much 
over time.11 These numbers make it difficult to argue that closing schools is slowing the spread of the 
disease to the most vulnerable people in the state, and therefore is an effective policy.  
It turns out that we have evidence from Kentucky that it is possible to conduct randomized testing 
of individuals to produce more accurate, unbiased estimates of the spread of the COVID-19 in at least one 
part of the State. The University of Louisville’s Co-Immunity project has already conducted two waves of 




11 This is based on data on the number of deaths in congregate living facilities available on the State of 




already shown a higher prevalence of the coronavirus in Jefferson County than was indicated by data on 
new reported cases produced by the State and, importantly, higher rates of survival than found in the 
reported data. They have also found that the rate of infection is much higher in western Jefferson County 
than in other parts of the county, something that cannot be detected with the State data, which then means 
that the appropriate resources to fight COVID-19 are not being distributed to the correct locations. 
Finally, using these data researchers on the Co-Immunity study will be able to calculate an accurate 
infection fatality rate for the entire population and by age. These data will allow policy makers in 
Louisville to assess the risk as well as the benefits of keeping businesses and schools open, producing 
better policy decisions. This project has been at least partially funded by private sector business leaders 
because business leaders understand the importance of having high quality, accurate data when making 
important decisions. Similar random testing has also been conducted in Indiana so it is hard to understand 
why all states, including Kentucky, refuse to incorporate random testing into their tools being used to 
track the spread of COVID-19.  
Evidence on the cost of shutting down schools and businesses, along with the IFR estimates by 
age and the share of deaths in Kentucky by age make clear that people under 65 are paying the biggest 
share of the cost of fighting the disease but are receiving the smallest share of the benefits. Given this, it is 
not surprising that parents are pushing for schools to reopen and people around the world are protesting 
efforts to reclose the economy. It would seem like the best course forward would be to obtain better data, 
and use the reliable data we already have such as data by on death rates and IFR by age to better direct 
efforts and resources at fighting the virus so we can protect the elderly and children while keeping schools 
and businesses open.   
The coronavirus is a serious disease that is imposing enormous costs on the people of Kentucky 
through an increase in the number of people getting sick, being hospitalized, and ultimately dying. 
However, the costs of the polices designed to help slow the spread of the disease, such as closing 
businesses and schools, are also large (See Coomes, 2020 for a discussion of these costs) so it is 
important to ensure that we are adopting the most efficient, effective, and well targeted policies to combat 
the disease, which requires having the necessary data to design and assess these policies. Failing use the 
best data results in a waste of taxpayer money and leads to unnecessary deaths. Unfortunately, given the 
limitations of the existing data resources, public officials do not have any better understanding of how the 
disease is spreading throughout the State or the deadliness of the disease than they did back in March, 
meaning policy decisions moving forward are going to be as inaccurate as ones made in the past. Given 
the impact of the disease it is hard to understand why the state continues to ignore the recommendation of 
the National Academy of Sciences, Engineering and Medicine, as well as the evidence for random testing 
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programs implemented in Jefferson County and Indiana, and devote at least some portion of their testing 
budget to periodically testing random samples of the population so that we can develop better measures of 
how the disease spreads through communities, a better understanding of the fatality of the disease, and 
better measures to protect the most vulnerable people in Kentucky while limiting the economic and social 
burden of public health policies. Given the enormous costs the disease is imposing on Kentuckians, it 
seems worth making the relatively small investments in collecting better data that could help save 
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